Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x100px
Organisation › Details

Mercia (Group)

Mercia Ventures is a proactive venture capital investor focused on being the first-choice partner for growth. Mercia Ventures makes equity investments of up to £10million across all sectors, with specialisms in Software, Consumer, Healthcare and Deep Tech.  Mercia Ventures is part of Mercia Asset Management PLC and sits alongside its wider private equity, debt and proprietary balance sheet capital operations. The Group has 11 offices in the UK and Mercia Ventures’ national footprint and 48 strong investment team draws on their experiences as founders, PhD scientists, software engineers, corporate financiers and management consultants to help our partner companies successfully achieve their ambitions. Mercia Asset Management PLC currently has c.£1.4billion of assets under management and, since its IPO in December 2014, has a portfolio of over 400 start-ups from pre-seed to Series B. Mercia Asset Management PLC is quoted on AIM with the epic "MERC". The Group raises its own Venture Capital Trusts (VCTs) and Enterprise Investment Scheme (EIS) Funds and details about open offers can be found through Mercia’s website. Mercia Asset Management PLC is quoted on AIM with the epic "MERC" and includes the following wholly owned subsidiaries - > Mercia Fund Management Limited is authorised and regulated by the FCA under firm reference number 524856 > Enterprise Ventures Limited is authorised and regulated by the FCA under firm reference number 183363 > EV Business Loans Limited is authorised and regulated by the FCA under firm reference number 443560 *

 

Period Start 2015-05-31 existent
Products Industry finance
  Industry 2 investment banking
Persons Person Payton, Mark (Mercia 202402 CEO of Mercia Asset Management formerly Oxxon 200504)
  Person 2 Glanfield, Martin (Mercia Technologies 201610 CFO)
     
Region Region United Kingdom (town unspecified)
  Country United Kingdom (GB)
  Street 17 High Street
Forward House
  City B95 5AA Henley-in-Arden
  Tel +44-330-223-1430
    Address record changed: 2024-01-05
     
Basic data Employees C: 51 to 100 (2020-03-31)
  Currency GBP
  Annual sales 1,400,000,000 (assets under management (2023) 2023-07-03)
  Profit -17,454,000 (2020-03-31)
     
    * Document for »About Section«: Newcells Biotech Ltd.. (2/14/24). "Press Release: Biotech Raises further £2.35m for Lab Models that Help Avoid Animal Testing".
     
   
Record changed: 2024-02-19

Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x200px

More documents for Mercia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x300px




» top